Safi Bahcall Overview

  • Investor Type
  • Angel

Safi Bahcall General Information


Dr. Safi Bahcall is an Angel Investor. He was the President and Chief Executive Officer at Synta. He is also the co- founder of Synta. Dr. Bahcall has led Synta from inception through multiple acquisitions, financings, an initial public offering, and the establishment of integrated, multi-product drug discovery and development organization. Prior to founding Synta, Dr. Bahcall was a consultant at McKinsey & Company advising investment banks and pharmaceutical companies on strategy, technology, and operations. Dr. Bahcall also co-founded a drug discovery company focused on novel ion channel research, now part of Synta. Dr. Bahcall received his B.A. summa cum laude in Physics from Harvard University, was awarded his Ph.D. from Stanford University in theoretical physics, and was a Miller postdoctoral fellow in condensed matter physics at U.C. Berkeley. In 2008, Dr. Bahcall was named Ernst & Young New England Biotechnology/Pharmaceutical Entrepreneur of the Year. He is currently a member of a working group on the future of the U.S. science and technology research enterprise, which consults with the President's Council of Advisers on Science and Technology (PCAST).

Contact Information

Primary Investor Type
Angel (individual)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Safi Bahcall Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Safi Bahcall Team (1)

Name Title Deals Funds Boards Office
Safi Bahcall Ph.D Angel Investor
To view Safi Bahcall’s complete team members history, request access »